Literature DB >> 2580655

Specificities and characteristics of mitochondrial protein antigens assessed by enzyme linked immunosorbent assay for anti-mitochondrial antibodies. Relationship to immunofluorescent and precipitating antibodies.

R C Gupta.   

Abstract

M-A, M-B and M-C are autoantibodies to mitochondrial proteins frequently found in primary biliary cirrhosis. To study the characteristics and specificities and to isolate antigens reacting with the autoantibodies a sensitive assay (ELISA) was established. Using this technique a significantly elevated level of antibodies was detected in patients with primary biliary cirrhosis (mean OD 460.2, s.d. 145.8) compared to normals (133.7 +/- 49.7). The assay correlated well with the indirect immunofluorescence test for detecting anti-mitochondrial antibodies and the mitochondrial fluorescence could be abolished by absorption of autoantibodies with the mitochondrial fraction. All three types of antibodies could be detected by ELISA; however, sera containing the combination of two or more antibodies yielded higher ELISA values. The ELISA confirmed that the M-A antigen is trypsin and acid (pH 3.0) sensitive but DNAase and RNAase resistant while the M-B antigen is DNAase and trypsin sensitive. The antigens were enriched in the supernatant isolated from the mitochondrial fraction centrifuged at 1,800 g for 60 min and 2% polyethylene glycol precipitates of the mitochondrial fraction. The antigens were found phosphate buffer soluble and therefore could also be enriched by phosphate buffer extraction of the mitochondrial proteins. Thus, ELISA described here provided a sensitive method in the assessment of characteristics and purification of autoantigens related to mitochondrial antibodies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580655      PMCID: PMC1576929     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Mitochondrial antibody in primary biliary cirrhosis and other diseases.

Authors:  G Klatskin; F S Kantor
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

2.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

3.  Lead content of milks fed to infants--1971-1972.

Authors:  S Lamm; B Cole; K Glynn; W Ullmann
Journal:  N Engl J Med       Date:  1973-09-13       Impact factor: 91.245

4.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

5.  Rheumatic disorders in primary biliary cirrhosis.

Authors:  A K Clarke; R M Galbraith; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

Review 6.  The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis.

Authors:  H Baum; P A Berg
Journal:  Semin Liver Dis       Date:  1981-11       Impact factor: 6.115

7.  The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis.

Authors:  H P Schultheiss; P Berg; M Klingenberg
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

8.  Preciitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis.

Authors:  K Miyachi; R C Gupta; E R Dickson; E M Tan
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features.

Authors:  R C Gupta; E R Dickson; F C McDuffie; A H Baggenstoss
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

10.  Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens.

Authors:  F Meek; E L Khoury; D Doniach; H Baum
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

View more
  1 in total

1.  Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.

Authors:  M Fusconi; I Ghadiminejad; F B Bianchi; H Baum; G F Bottazzo; E Pisi
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.